Lamivudine
NDC 68180-602 · Lupin Pharmaceuticals, Inc.
Generic nameLamivudine
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)LAMIVUDINE
Strength150 mg/1
Pharmacologic classHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
Marketing categoryANDA
Packages
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
60505-3251 — lamivudine, 60505-3252 — lamivudine, 60687-720 — Lamivudine, 62135-706 — lamivudine oral, 64380-710 — Lamivudine, 64380-711 — Lamivudine, 65862-025 — Lamivudine, 65862-026 — Lamivudine, 65862-036 — Lamivudine and Zidovudine, 65862-055 — Lamivudine, 65862-335 — Abacavir and Lamivudine, 67046-1459 — Lamivudine, 68180-286 — ABACAVIR , LAMIVUDINE AND ZIDOVUDINE, 68180-288 — Abacavir and Lamivudine, 68999-706 — lamivudine oral, 69097-362 — Abacavir and lamivudine, 71335-0639 — LAMIVUDINE and ZIDOVUDINE, 71335-1916 — Lamivudine and Zidovudine, 72865-144 — lamivudine and zidovudine, 76282-115 — Lamivudine and Zidovudine, +32 more